Intraoperative radioimmunolocalization of colorectal cancer: A review

C. Aprile

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Although intraoperative radioimmunolocalization (IORIL) is gaining wider acceptance, several limits inhibit a more extensive clinical use. In this paper the following topics will be discussed: 1) the clinical approach, that is, the combined use of immunoscintigraphy and IORIL after a single M Ab administration or the use of non-imaging 125 I M Ab; 2) the detector type and its collimation and shielding; 3) the nuclides employed, and 4) the background problem. The clinical results of our and other groups show a sensitivity that is generally higher than 0.75 with a high positive predictive value. The detection rate of occult lesions is in the order of 20% of all explored sites. However, the current state of detector and M Ab technology do not allow to achieve better results; probably the results can be improved by the use of bispecific M Ab or the avidin-biotin system.

Original languageEnglish
Pages (from-to)166-171
Number of pages6
JournalInternational Journal of Biological Markers
Volume8
Issue number3
Publication statusPublished - 1993

Fingerprint

Avidin
Biotin
Colorectal Neoplasms
Technology
Detectors
Shielding
Isotopes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology

Cite this

Intraoperative radioimmunolocalization of colorectal cancer : A review. / Aprile, C.

In: International Journal of Biological Markers, Vol. 8, No. 3, 1993, p. 166-171.

Research output: Contribution to journalArticle

@article{d2777dc8da374e89922989c4e35e1ea1,
title = "Intraoperative radioimmunolocalization of colorectal cancer: A review",
abstract = "Although intraoperative radioimmunolocalization (IORIL) is gaining wider acceptance, several limits inhibit a more extensive clinical use. In this paper the following topics will be discussed: 1) the clinical approach, that is, the combined use of immunoscintigraphy and IORIL after a single M Ab administration or the use of non-imaging 125 I M Ab; 2) the detector type and its collimation and shielding; 3) the nuclides employed, and 4) the background problem. The clinical results of our and other groups show a sensitivity that is generally higher than 0.75 with a high positive predictive value. The detection rate of occult lesions is in the order of 20{\%} of all explored sites. However, the current state of detector and M Ab technology do not allow to achieve better results; probably the results can be improved by the use of bispecific M Ab or the avidin-biotin system.",
author = "C. Aprile",
year = "1993",
language = "English",
volume = "8",
pages = "166--171",
journal = "International Journal of Biological Markers",
issn = "0393-6155",
publisher = "Wichtig Publishing Srl",
number = "3",

}

TY - JOUR

T1 - Intraoperative radioimmunolocalization of colorectal cancer

T2 - A review

AU - Aprile, C.

PY - 1993

Y1 - 1993

N2 - Although intraoperative radioimmunolocalization (IORIL) is gaining wider acceptance, several limits inhibit a more extensive clinical use. In this paper the following topics will be discussed: 1) the clinical approach, that is, the combined use of immunoscintigraphy and IORIL after a single M Ab administration or the use of non-imaging 125 I M Ab; 2) the detector type and its collimation and shielding; 3) the nuclides employed, and 4) the background problem. The clinical results of our and other groups show a sensitivity that is generally higher than 0.75 with a high positive predictive value. The detection rate of occult lesions is in the order of 20% of all explored sites. However, the current state of detector and M Ab technology do not allow to achieve better results; probably the results can be improved by the use of bispecific M Ab or the avidin-biotin system.

AB - Although intraoperative radioimmunolocalization (IORIL) is gaining wider acceptance, several limits inhibit a more extensive clinical use. In this paper the following topics will be discussed: 1) the clinical approach, that is, the combined use of immunoscintigraphy and IORIL after a single M Ab administration or the use of non-imaging 125 I M Ab; 2) the detector type and its collimation and shielding; 3) the nuclides employed, and 4) the background problem. The clinical results of our and other groups show a sensitivity that is generally higher than 0.75 with a high positive predictive value. The detection rate of occult lesions is in the order of 20% of all explored sites. However, the current state of detector and M Ab technology do not allow to achieve better results; probably the results can be improved by the use of bispecific M Ab or the avidin-biotin system.

UR - http://www.scopus.com/inward/record.url?scp=0027527124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027527124&partnerID=8YFLogxK

M3 - Article

C2 - 8277208

AN - SCOPUS:0027527124

VL - 8

SP - 166

EP - 171

JO - International Journal of Biological Markers

JF - International Journal of Biological Markers

SN - 0393-6155

IS - 3

ER -